Why the study?
This review summarizes the functional roles of cardiac RGS proteins and their implications for treating HF and AFib, focusing on RGS4 as a therapeutic target.
Design
Review
Authors
Loading...
Hypothesis-generating for RGS4-targeted therapies in heart failure; leaves open clinical efficacy in atrial fibrillation.
RGS4 is upregulated in human heart failure and may serve as a compensatory, cardioprotective mechanism by terminating maladaptive Gq and Gi/o protein signaling, highlighting its potential as a therapeutic target.
Borges et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: